| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 06/21/2006 | CN1259936C Chinese-western combined medicine for treating burn and scald |
| 06/21/2006 | CN1259932C Suppository for detoxicating and promoting blood circulation and its preparation method |
| 06/21/2006 | CN1259926C Medicine for preventing allergy of dentin |
| 06/21/2006 | CN1259921C New medicine for treating beriberi |
| 06/21/2006 | CN1259919C Sterilizing and bacteria inhibiting pharmaceutical composition and its formulation and preparation process |
| 06/21/2006 | CN1259918C Use of bile acid or bile salt fatty acid conjugates |
| 06/21/2006 | CN1259917C Cefixime pharmaceutical composition for injection |
| 06/21/2006 | CN1259916C Preparation process of antifungal itraconazole containing freeze dried powder injection and transfusion |
| 06/21/2006 | CN1259915C Effective-component extract of Foliun-Mori and its preparation method |
| 06/21/2006 | CN1259914C Use of scopoletin in preparing medicine for preventing and curing hyperuricemia |
| 06/21/2006 | CN1259913C Daphnetin and arteannuin derivative compatible anti-malaria composition |
| 06/21/2006 | CN1259912C Citalopram for the treatment of elevated blood pressure |
| 06/21/2006 | CN1259911C Carbamate compounds for use in preventing or treating neuropathic pain and cluster and migraine headache-associated pain |
| 06/21/2006 | CN1259910C Liquid drug preparations |
| 06/21/2006 | CN1259909C Medicinal composition containing 2,2-dichloro-12-(4-chlorophenyl)dodecanoic acid |
| 06/21/2006 | CN1259908C Hydrolysis-optimized liplid emulsions and use thereof |
| 06/21/2006 | CN1259907C Pseudoephedrine hydrochloride dripping pill |
| 06/21/2006 | CN1259906C Ambroxol hydrochloride containing hydroxypropyl beta-cyclodextrin and its preparation |
| 06/21/2006 | CN1259905C Use of Rhizoma-Curcumae-Longae element in preparing medicine for treating lung disease |
| 06/21/2006 | CN1259904C Medicinal composition with sodium houttuy fonate and ambroxol hydrochloride and its uses |
| 06/21/2006 | CN1259903C Slow release bioadhesive buccal tablet |
| 06/21/2006 | CN1259902C Process for producing nanoparticles of paclitaxel and albumin |
| 06/21/2006 | CN1259844C Mixtures of fructose and lactose as low-calorie bulk sweetener with reduced blood sugar index |
| 06/21/2006 | CA2530964A1 Crystalline form of rabeprazole sodium |
| 06/20/2006 | USRE39140 pyridylmethylamines such as 1-(2-chloro-5-thiazolylmethyl)-2-cyanoiminoimidazolidine used as insecticides |
| 06/20/2006 | US7065467 Method and apparatus for system management using codebook correlation with symptom exclusion |
| 06/20/2006 | US7064229 Succinic acid derivatives |
| 06/20/2006 | US7064220 Production of furanones |
| 06/20/2006 | US7064218 Aromatic compounds and poly(oxyalkylene) containing aromatic compounds possessing antibacterial, antifungal or antitumor activity |
| 06/20/2006 | US7064217 2-Aminoacetamide derivatives with hydroxy-, phosphonate-, and/or methylene phosphonate substituent; antitumor, anticoagulant, antiproliferative, and wound healing agents |
| 06/20/2006 | US7064215 Nitrogen compounds such as 3-(5-morpholin-4-yl-1H-benz-imidazol-2-yl)-1H-indazole and/or isomers, used as immunology modulators, antidiabetic agents, antiogenesis inhibitors or for prophylaxis of Alzheimer's disease |
| 06/20/2006 | US7064211 Hemiasterlin derivatives and uses thereof |
| 06/20/2006 | US7064208 Substantially pure cilostazol and processes for making same |
| 06/20/2006 | US7064207 Androgen receptor antagonists |
| 06/20/2006 | US7064204 Nitrogen compounds such as 4-(5-amino-7-phenethyl-7H-pyrazolo (4,3-e)(1,2,4)triazolo(1,5-c)pyrimidin-2-yl)-phenol, used as adenosine receptor antagonists, for prophylaxis of nervous, cardiovascular, respiratory, urogenital and immune disorders |
| 06/20/2006 | US7064203 Di-substituted pyrrolotriazine compounds |
| 06/20/2006 | US7064200 Process for the synthesis of 1,3,4,5-tetrahydro-2H-3-benzazepin-2-one compounds, and application in the synthesis of ivabradine and addition salts thereof with a pharmaceutically acceptable acid |
| 06/20/2006 | US7064198 For treating human/animal gram-positive/negative bacteria infections |
| 06/20/2006 | US7064194 Vectors for animal cells and utilization thereof |
| 06/20/2006 | US7064190 An isolated complex of a peptide of glutamic acid decarboxylase(with specific 6 contiguous amino acids), and an allele of MHC class II molecules DR3 and DR4; useful for diagnosis and therapy of autoimmune diseases |
| 06/20/2006 | US7064189 Antibodies that immunospecifically bind to trail receptors |
| 06/20/2006 | US7064185 Antibody for human Cyr61 |
| 06/20/2006 | US7064168 AnB block copolymers containing poly (vinyl pyrrolidone) units, medical devices, and methods |
| 06/20/2006 | US7064148 Such as 13,14-dihydro-15-keto-16,16-difluoro-prostaglandin E for treatment of cystic fibrosis; lubiprostone |
| 06/20/2006 | US7064147 Amino acids with affinity for the α-2-delta-protein |
| 06/20/2006 | US7064146 Pharmaceutical compositions of isolated orthorhombic crystalline 4-[6-acetyl-3-[3-(4-acetyl-3-hydroxy-2-propylphenylthio)propoxy]-2-propylphenoxy]butyric acid and methods of use |
| 06/20/2006 | US7064145 Inhibition of beta cell degeneration |
| 06/20/2006 | US7064144 Imidazole derivatives as adenosine deaminase inhibitors |
| 06/20/2006 | US7064143 4-oxy- or amino-substituted indole-2-carboxy acids, esters and amides, e.g., ethyl 4-hydroxy-1-methyl-1H-indole-2-carboxylate and N-methyl-N-phenethyl 4-hydroxy-1-methyl-1H-indole-2-carboxamide; used for treatment of Alzheimer's disease, anxiety or schizophrenia |
| 06/20/2006 | US7064142 Imidazonline compounds |
| 06/20/2006 | US7064141 Method for preventing, treating or inhibiting development of simple retinopathy and preproliferative retinopathy |
| 06/20/2006 | US7064140 linked via an alkylene bridge to the nitrogen atom of a 1,2-benzisothiazol-3(2H)-one 1,1-dioxide group; also containing an opioid analgesic; enhanced analgesic potency and are free from antipyretic activity, do not suppress blood coagulation, and have little hepatotoxic effect. |
| 06/20/2006 | US7064139 Prevention reproduction of virus |
| 06/20/2006 | US7064138 Also treating bulimia nervosa, irritable bowel syndrome, urinary incontinence, asthma, bradycardia, and bradyarrhythmia |
| 06/20/2006 | US7064137 Analgesics; anxiolytic agents; gastrointestinal disorders |
| 06/20/2006 | US7064136 Central nervous system disorders; psychological disorders; schizophrenia; antiarthritic agents; Alzheimer's disease; anticancer agents |
| 06/20/2006 | US7064135 Antihistamines; anticholesterol agents; cardiovascular disorders; antidiabetic agents; anticancer agents |
| 06/20/2006 | US7064134 4-piperidinyl-substituted, e.g., 4-(2-methyl-4-piperidin-1-yl-quinolin-7-ylmethoxy)-benzonitrile; treating eating disorders and obesity |
| 06/20/2006 | US7064133 A 2-carbamoyl-8-hydroxyquinoline-7-carboxylic acid compound or its salt, e.g., 2-(3,4-dihydroxybenzylcarbamoyl)-8-hydroxyquinoline-7-carboxylic acid or its sodium salt, useful as a retrovirus integrase inhibitor, especially for treatment of HIV |
| 06/20/2006 | US7064132 Administering an aerosolized mixture of lipid crystals comprised of a mixture of one or more lipids surfactants and spreading agents in powder form and propellants directly to the ear canal |
| 06/20/2006 | US7064131 Compounds and methods for inhibiting MRP1 |
| 06/20/2006 | US7064130 Using dipyridamole or mopidamol in doses lower than those needed to directly inhibit platelet aggregation alone or with a substance that increases nitric oxide production such as a hmg coa reuctase inhibitor |
| 06/20/2006 | US7064129 e.g., N-(3,5-diamino-6-chloropyrazine-2-carbonyl)-N'-(4-{4-[3-(1H-tetrazol-5-yl)propoxy]phenyl}butyl)guanidine hydrochloride; used to hydrate mucosal surfaces; are absorbed less rapidly, thus have a prolonged pharmacodynamic half-life |
| 06/20/2006 | US7064128 Preferentially substituted calcium channel blockers |
| 06/20/2006 | US7064127 Treatment of hepatic fibrosis with imatinib mesylate |
| 06/20/2006 | US7064126 Compounds |
| 06/20/2006 | US7064124 nuclear factor (NF); inflammatory diseases, autoimmune diseases and viral diseases; 4-(3,4,5,6-tetramethoxy-2-methylbenzyl)-2-benzyloxybenzoic acid or 4-(5,6-dimethoxy-3-methyl-1,4-benzoquinon-2-yl)methyl-2-benzyloxybenzoic acid, for example |
| 06/20/2006 | US7064123 substituted acetamides; uses for treating diseases including arthritis, muscular dystrophy, inflammation, tumor invasion, glomerulonephritis, malaria, periodontal disease, and metachromatic leukodystrophy |
| 06/20/2006 | US7064122 Pancreatic lipase inhibitor compounds, their synthesis and use |
| 06/20/2006 | US7064121 benzodiazepine derivatives that may be fused to a pyrroline or piperidine ring; e.g., N-[1 (R)-(3-Aminopropylcarbamoyl)-2-(naphthalen-2-yl)ethyl]-3-(5,11-dioxo-2,3-dihydro-1H-(11aS)-pyrrolo[2,1-c][1,4]benzodiazepin-10-yl)propionamide; increasing levels of endogenous growth hormones in humans and animals |
| 06/20/2006 | US7064120 For prevention and/or suppression of preterm labor, suppression of labor at term prior to caesarean delivery, and for the treatment of dysmenorrhea; useful in enhancing fertility rates |
| 06/20/2006 | US7064119 with a hexahydro-5-oxo-4-phenylpyrimido[4,5-b][1,5]diazocine or tetrahydro-5H-pyrimido[4,5-e][1,4]diazepin e ring; treating dysuria, especially increased urinary frequency or incontinence |
| 06/20/2006 | US7064118 Cholinergic ligands of the nicotinic acetyl choline receptors; modulators; nervous system disordes, analgesics; smooth muscle contraction; antiinflammatory agents; drug abuse, including smoking; Alzheimer's disease; Parkinson's disease; cognition |
| 06/20/2006 | US7064117 Anti-cancer 2,3-dihydro-1H-pyrrolo[3,2-f]quinoline complexes of cobalt and chromium |
| 06/20/2006 | US7064116 GABAA modulating neurosteroids |
| 06/20/2006 | US7064115 (20S)-1α-hydroxy-2α-methyl and 2β-methyl-19-nor-vitamin D3 and their uses |
| 06/20/2006 | US7064114 Gel-microemulsion formulations |
| 06/20/2006 | US7064112 selectively inhibiting abnormal cell proliferation by administering an A3-selective adenosine A3 receptor agonist in an amount of less than 100 mu g/Kg body weight. |
| 06/20/2006 | US7064110 Macrolide antibiotics |
| 06/20/2006 | US7064109 Pharmaceutical composition based on macrolides for topical application in ophthalmology |
| 06/20/2006 | US7064108 Topical ivermectin composition |
| 06/20/2006 | US7064104 Methods of managing the symptoms of premenstrual syndrome |
| 06/20/2006 | US7063971 Phosphodiesterase enzymes |
| 06/20/2006 | US7063965 especially that encodes an immunoglobulin constant region such as the Fc portion of human IgG1. |
| 06/20/2006 | US7063963 Nucleotide sequences consisiting of DNA viral open reading frames which code proteins which can be used to prepare genetic vaccines which prevent viral diseases |
| 06/20/2006 | US7063958 that encode a receptor for leptin, including a naturally occurring soluble form of the receptor that is expected to modulate, especially agonize, leptin activity; could be used to treat obesity |
| 06/20/2006 | US7063865 Mixture of glycine, glutathione, vitamins and minerals; hangover therapy |
| 06/20/2006 | US7063864 Morphine sulphate microgranules, method for preparing same and compositions containing same |
| 06/20/2006 | US7063862 Pharmaceutical composition and method for treating |
| 06/20/2006 | US7063861 Bioavailable composition of natural and synthetic HCA |
| 06/20/2006 | US7063857 Use of macrolide compounds for the treatment of dry eye |
| 06/20/2006 | US7063856 Aromatic amidoalkylnitrile compounds for treating domastic animals infected by endoparasites, especially helminths |
| 06/20/2006 | US7063853 DNA immunization against Chlamydia infection |
| 06/20/2006 | US7063835 Virus strains |
| 06/20/2006 | US7063832 Treating musculoskeletal pain or restless leg syndrome by breathing a muscle relaxant condensation aerosol having a mass median aerodynamic diameter (MMAD) of <3 mu m and <5% relaxant degradation products; kits; heating a coating of drug on a support to vaporize and passing air through the heated vapors |
| 06/20/2006 | US7063831 Delivery of erectile dysfunction drugs through an inhalation route |
| 06/20/2006 | US7063830 condensation aerosol for delivery of lidocaine, verapamil, diltiazem, isometheptene and lisuride, wherein aerosol is formed by heating a thin layer containing the drug, on a solid support, to produce a vapor of the drug, and condensing the vapor to form aerosol |
| 06/20/2006 | US7063745 Coating formulation kit including a catalyst solution dispenser for a hand-held liquid spraying apparatus |
| 06/20/2006 | CA2388334C Thermosensitive cyclotriphosphazene-platinum complex conjugate, its preparation method and anticancer agent containing the same |
| 06/20/2006 | CA2379633C Amino substituted pyrazolo[1,5,-a]-1,5-pyrimidines and pyrazolo[1,5-a]-1,3,5-triazines |